Enfenamic Acid

Enfenamic Acid

SCHEMBL25191

O=C(O)c1ccccc1NCCc1ccccc1

nearest known ligand 0.68

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM6B O15054 3/20 0.68
KDM4C Q9H3R0 3/20 0.68
ALDH1A1 P00352 4/20 0.67
HSD17B10 Q99714 3/20 0.67
HPGD P15428 2/20 0.67
MAPT P10636 2/20 0.61
KDM4E B2RXH2 5/20 0.60
ASPH Q12797 4/20 0.60
KDM8 Q8N371 4/20 0.60
RIOX2 Q8IUF8 3/20 0.60
L3MBTL1 Q9Y468 2/20 0.57
POLB P06746 1/20 0.57
CTDSP1 Q9GZU7 1/20 0.57
AGTR1 P30556 1/20 0.56
RAB9A P51151 1/20 0.56
PLK1 P53350 1/20 0.55
RXFP1 Q9HBX9 1/20 0.53
CFD P00746 1/20 0.53
ABCC1 P33527 1/20 0.51
PKM P14618 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Enfenamic Acid SCHEMBL10935569 0.98 KDM6B (0.66) KDM6BKDM4CALDH1A1HSD17B10HPGD
SCHEMBL28655011 0.90 KDM6B (0.57) KDM6BKDM4CALDH1A1HSD17B10HPGD
SCHEMBL1116005 0.90 ALDH1A1 (0.72) KDM6BKDM4CALDH1A1HSD17B10HPGD
SCHEMBL4897624 0.90 KDM6B (0.69) KDM6BKDM4CALDH1A1HSD17B10HPGD
SCHEMBL13199682 0.88 KDM6B (0.70) KDM6BKDM4CALDH1A1HSD17B10HPGD
SCHEMBL11499132 0.87 KDM6B (0.68) KDM6BKDM4CALDH1A1HSD17B10HPGD
SCHEMBL8689214 0.87 ALDH1A1 (0.79) KDM6BKDM4CALDH1A1HSD17B10HPGD
SCHEMBL12608931 0.86 RXFP1 (0.54) KDM6BKDM4CALDH1A1HSD17B10HPGD
SCHEMBL5387032 0.86 SIRT2 (0.63) KDM6BKDM4CALDH1A1HSD17B10HPGD
SCHEMBL27823112 0.85 RXFP1 (0.60) KDM6BKDM4CALDH1A1HSD17B10HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 3567 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4046491-B1 CONSUMER CARE PRODUCT FMC CORP (US) 2026-04-29 EP claimed
US-20250287942-A1 FORMULATIONS FOR REPELLING BEES AND OTHER INSECTS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2025-09-18 US claimed
EP-4510829-A2 FORMULATIONS FOR REPELLING BEES AND OTHER INSECTS The Regents of University of California (US) 2025-02-26 EP claimed
EP-4470565-A1 METHOD FOR PREVENTING OR TREATING DISEASE OR DISORDER ASSOCIATED WITH ANTINEOPLASTIC AGENT OnQuality Pharmaceuticals China Ltd. (CN) 2024-12-04 EP claimed
CN-118742325-A Methods for preventing or treating diseases or conditions associated with antineoplastic agents 上海岸阔医药科技有限公司 2024-10-01 CN claimed
US-20240041935-A1 PREVENTION AND TREATMENT OF REPRODUCTIVE FAILURE BY REGENERATIVE CELLS AND ADJUVANTS CREATIVE MEDICAL TECHNOLOGIES, INC. (US) 2024-02-08 US claimed
WO-2023205458-A2 FORMULATIONS FOR REPELLING BEES AND OTHER INSECTS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2023-10-26 WO claimed
WO-2023142996-A1 METHOD FOR PREVENTING OR TREATING DISEASE OR DISORDER ASSOCIATED WITH ANTINEOPLASTIC AGENT 上海岸阔医药科技有限公司 2023-08-03 WO claimed
EP-3998932-A1 ALKALIZATION OF URINARY BLADDER WALL PRIOR TO TREATMENT WITH INTRAVESICAL HEPARIN AND ALKALINIZED LIDOCAINE TO ENHANCE RELIEF OF BLADDER PAIN SYMPTOMS Parsons, C. Lowell (US) 2022-05-25 EP claimed
US-20210145763-A1 LOW THC HEMP EXTRACT AND METHOD OF TREATMENT OR PREVENTION OF AN EYE DISEASE EYE CO PTY LTD. (AU) 2021-05-20 US claimed
EP-0786999-A4 COMBINATION METHOD FOR ACNE TREATMENT MERCK & CO INC (US) 1999-01-20 EP claimed
EP-0792371-A4 COMBINATION METHOD FOR ACNE TREATMENT MERCK & CO INC (US) 1998-12-30 EP claimed
WO-1998022114-A1 A METHOD FOR PROMOTING TISSUE REPAIR DUMEX-ALPHARMA A/S (DK) 1998-05-28 WO claimed
WO-1998009948-A2 NITRIC ESTER DERIVATIVES AND THEIR USE IN URINARY INCONTINENCE AND OTHER DISEASES NICOX S.A. (FR) 1998-03-12 WO claimed
EP-0792371-A1 COMBINATION METHOD FOR ACNE TREATMENT Merck & Co., Inc. (US) 1997-09-03 EP claimed
EP-0786999-A1 COMBINATION METHOD FOR ACNE TREATMENT Merck & Co., Inc. (US) 1997-08-06 EP claimed
US-5543417-A 5 Alpha-reductase inhibitor and at least one of an antibacterial agent, a keratolytic agent or an anti-inflammatory agent MERCK & CO., INC. (US) 1996-08-06 US claimed
WO-1996012487-A1 COMBINATION METHOD FOR ACNE TREATMENT MERCK & CO., INC. (US) 1996-05-02 WO claimed
WO-1996012817-A1 COMBINATION METHOD FOR ACNE TREATMENT MERCK & CO., INC. (US) 1996-05-02 WO claimed
EP-0071682-B1 NEW ANTHRANILIC ACID ESTERS HAVING ANTI-INFLAMMATORY ACTIVITY AND THEIR PREPARATION Council of Scientific and Industrial Research (IN) 1985-11-13 EP claimed